Related Experiment Videos
Inhibition of chemical carcinogenesis by viral vaccines
Abstract:
The incidence of 3-methylcholanthrene-induced subcutaneous tumors was significantly reduced by a single injection of inactivated type C RNA viral vaccine. Rauscher leukemia virus vaccine reduced the incidence of sarcomas from 78 to 50 percent in the BALB/cCr mouse. Radiation leukemia virus vaccine and a vaccine from a wild murine leukemia virus derived from a 3-methylcholanthrene tumor reduced the incidence of sarcoma from 86 percent to 33 and 37 percents, respectively, in the C57BL/6 mouse. These reductions in tumor incidence by virus vaccines help support the concept that type C RNA viruses serve as determinants of chemically induced cancer; additional studies of vaccines made with more purified virus preparations are necessary.
Insights
Viral vaccines significantly reduced chemically induced tumors in mice. This supports the role of type C RNA viruses in chemical carcinogenesis, warranting further research with purified vaccines.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Chemical carcinogens like 3-methylcholanthrene induce tumors.
- Type C RNA viruses are implicated in the development of chemically induced cancers.
- Murine leukemia viruses are a focus of cancer research.
Purpose of the Study:
- To investigate the efficacy of inactivated type C RNA viral vaccines in preventing chemically induced tumors.
- To assess the role of specific viral vaccines in reducing sarcoma incidence in mice.
- To provide evidence supporting the hypothesis that type C RNA viruses are determinants in chemical carcinogenesis.
Main Methods:
- Mice (BALB/cCr and C57BL/6) were injected with 3-methylcholanthrene to induce subcutaneous tumors.
- Inactivated Rauscher leukemia virus vaccine, Radiation leukemia virus vaccine, or a wild murine leukemia virus vaccine were administered.
- Tumor incidence and sarcoma development were monitored and compared to control groups.
Main Results:
- A single injection of inactivated type C RNA viral vaccine significantly reduced 3-methylcholanthrene-induced tumor incidence.
- Rauscher leukemia virus vaccine decreased sarcoma incidence from 78% to 50% in BALB/cCr mice.
- Radiation leukemia virus vaccine and a wild murine leukemia virus vaccine reduced sarcoma incidence from 86% to 33% and 37%, respectively, in C57BL/6 mice.
Conclusions:
- Viral vaccines demonstrate a protective effect against chemically induced sarcomas in mice.
- These findings support the concept that type C RNA viruses play a role in chemically induced cancers.
- Further studies using purified virus preparations are needed to confirm these results.